Welcome to EMJ Gastroenterology 9.1, an issue that is essential reading for all those interested in novel and emerging therapies for inflammatory bowel disease, stem cell therapies for inflammation-associated sigmoid colon diseases, and other key developments in the field. Inside, we also present summaries of abstracts presented at UEG Week Virtual 2020, as well as interviews with UEG Council representatives.
EMJ Gastroenterology 9.1 2020
December 2020
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Thank you!
Please share some more information on the rating you have given